A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Clinical trial NCT02124668 · COMPLETED
Trial details
- NCT number
- NCT02124668
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-23
- Primary completion
- 2017-05-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.